Decade-Long watch: tracking a One-Time gene therapy for a lifelong bleeding disorder

NCT ID NCT05768386

Summary

This study aims to track the long-term safety and durability of a one-time gene therapy (BMN 270) for severe Hemophilia A over approximately 10 years. It will follow about 172 patients who received the therapy in earlier BioMarin trials. The main goal is to see if the treatment's benefits last and to monitor for any long-term side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Addenbrooke's Hospital, Hemophilia and Thrombophilia Center

    Cambridge, United Kingdom

  • Arthur De Siqueira Cavalcanti Hematology State Institute / Coordinating Hemocenter

    Rio de Janeiro, Rio de Janeiro, 24000-000, Brazil

  • CHRU Lille Hospital Center Heart-Lung Institute

    Lille, 59000, France

  • CHU La Timone - La Timone Children's Hospital

    Marseille, 13005, France

  • Campinas University Clinical Hospital, Hematology and Hemotherapy Center (Hemocentro UNICAMP)

    Campinas, São Paulo, 13083-878, Brazil

  • Chaim Sheba Medical Center, National Institute of Hemophilia and Coagulation

    Ramat Gan, 5266202, Israel

  • Charlotte Maxeke Johannesburg Academic Hospital, Hemophilia Comprehensive Care Center

    Johannesburg, 2193, South Africa

  • Children's Hospital of Michigan, Hemophilia and Thrombosis Center

    Detroit, Michigan, 48201, United States

  • Fiona Stanley Hospital

    Murdoch, Western Australia, 6150, Australia

  • Glasgow Royal Infirmary, Department of Hematology

    Glasgow, G4 0SF, United Kingdom

  • Hammersmith Hospital, Clinical Research Facility, Centre for Translational and Experimental Medicine

    London, United Kingdom

  • Hemophilia Center of Western Pennsylvania

    Pittsburgh, Pennsylvania, 15213, United States

  • Hemophilia and Thrombosis Center at the University of Colorado Anschutz Medical Campus

    Aurora, Colorado, 80045, United States

  • Holy Spirit Hematology and Hemotherapy Center

    Vitória, Espírito Santo, 29040-090, Brazil

  • Hospital Teresa Herrera, Department of Hematology and Hemotherapy, Unit of Hemostasis and Thrombosis

    A Coruña, Galicia, 15006, Spain

  • Kyung Hee University Hospital at Gangdong

    Seoul, 05278, South Korea

  • Maggiore Polyclinic Hospital, Foundation IRCCS Ca' Granda, Center for Hemophilia and Thrombosis "Angelo Bianchi Bonomi"

    Milan, 20122, Italy

  • Nationwide Children's Hospital

    Columbus, Ohio, 43205, United States

  • Nuffield Orthopaedic Centre, Hemophilia & Thrombosis Center

    Oxford, OX3 7LD, United Kingdom

  • Orthopedic Institute for Children, Orthopedic Hemophilia Treatment Center

    Los Angeles, California, 90007, United States

  • Queen Elizabeth Hospital Birmingham. Adult Hemophilia Centre, West Midlands Adult Comprehensive Care Hemophilia Centre

    London, United Kingdom

  • Royal Adelaide Hospital

    Adelaide, South Australia, 5000, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, 4029, Australia

  • Royal London Hospital, Barts and the London Hemophilia Center

    London, United Kingdom

  • Royal Prince Alfred Hospital, Institute of Haematology

    Sydney, New South Wales, 2050, Australia

  • Sao Paulo University Clinical Hospital

    São Paulo, São Paulo, 05403 000, Brazil

  • St Joseph's Children's Hospital, Center for Bleeding and Clotting Disorders

    Tampa, Florida, 33614, United States

  • St Thomas' Hospital, Centre for Hemophilia, Hemostasis and Thrombosis

    London, United Kingdom

  • The Alfred Hospital

    Melbourne, Victoria, 3004, Australia

  • UC Davis Hemophilia Treatment Center

    Sacramento, California, 95817, United States

  • UCN Hemophilia and Thrombosis Center

    Shandon, California, 27517, United States

  • University Hospital Bonn, Institute of Experimental Hematology and Transfusion Medicine, Hemophilia Care Center

    Bonn, North Rhine-Westphalia, 53127, Germany

  • University Hospital Southampton NHS Foundation Trust

    Southampton, United Kingdom

  • University Hospital Virgen del Rocio (HUVR), Hematology Pediatrics

    Seville, Andalusia, 41013, Spain

  • University Hospitals Leuven, Campus Gasthuisberg, Department of Heart and Vascular Disease

    Leuven, 3000, Belgium

  • University Medical Center, Inc,; DBA University of Louisville Hospital, James Graham Brown Cancer Center

    Louisville, Kentucky, 40202-3229, United States

  • University of California San Diego, Hemophilia & Thrombosis Treatment Center

    San Diego, California, 92121, United States

  • University of California San Francisco - Moffit Hospital, Outpatient Hematology Clinic

    San Francisco, California, 94143, United States

  • University of Michigan, Pediatric Hematology and Oncology

    Ann Arbor, Michigan, 48109-5718, United States

  • Vivantes Hospital in Friedrichshain

    Berlin, State of Berlin, 10249, Germany

  • Washington University School of Medicine, Department of Pediatrics, Division of Hematology/Oncology

    St Louis, Missouri, 63110-1093, United States

Conditions

Explore the condition pages connected to this study.